相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
Yurong Gu et al.
AGING-US (2020)
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
Qimin Zhou et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Response to Letter to the Editor Hyponatremia may be an under-recognised complication after desmopressin to reduce uremic bleeding in kidney biopsy
Bjorn Peters
NEPHROLOGY (2020)
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Matthias Van Haele et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN
Liwen Guo et al.
FEBS OPEN BIO (2019)
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Xiaotian Yuan et al.
ONCOGENE (2019)
JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer
Bo Chen et al.
AGING-US (2019)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma
Sang Yeon Cho et al.
ONCOLOGY REPORTS (2017)
Increased expression of YAP1 in prostate cancer correlates with extraprostatic extension
Filiz Kisaayak Collak et al.
CANCER BIOLOGY & MEDICINE (2017)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Roger R. Reddel
CURRENT PHARMACEUTICAL DESIGN (2014)
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells
Z. Liu et al.
ONCOGENE (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer
Xiaodan Wang et al.
EUROPEAN JOURNAL OF CANCER (2012)
EXPRESSION OF YES-ASSOCIATED PROTEIN IN GASTRIC ADENOCARCINOMA AND INHIBITORY EFFECTS OF ITS KNOCKDOWN ON GASTRIC CANCER CELL PROLIFERATION AND METASTASIS
J. Zhang et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
PrognoScan: a new database for meta-analysis of the prognostic value of genes
Hideaki Mizuno et al.
BMC MEDICAL GENOMICS (2009)
Yes-Associated Protein Is an Independent Prognostic Marker in Hepatocellular Carcinoma
Michelle Z. Xu et al.
CANCER (2009)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Telomere length homeostasis requires that telomerase levels are limiting
G Cristofari et al.
EMBO JOURNAL (2006)
The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression
ML Cayuela et al.
EMBO REPORTS (2005)
Clinical utility of telomerase in cancer
E Hiyama et al.
ONCOGENE (2002)
分享论文
